Barry F. Uretsky, MD

Our colleague and cath lab expert, Dr. Barry Uretsky from the University of Arkansas, Little Rock, started this conversation with one of the oldest and probably most important questions about coronary angiography, and that is, how should we...

Our colleague and cath lab...

01/06/2016

Cath Lab Digest

Original Contribution

The Impact of Proximal Vessel Tortuosity on the Outcomes of Chronic Total Occlusion Percutaneous Coronary Intervention: Insights From a Contemporary Multicenter Registry

05/15/2017

Ziad A. Ali , MD, DPhil;

Manish A. Parikh , MD;

Aris Karatasakis , MD;

Dimitrios Karmpaliotis , MD, PhD;

Barbara Anna Danek , MD;

Farouc A. Jaffer , MD, PhD;

Judit Karacsonyi , MD, PhD;

Robert W. Yeh , MD, MBA, MSc;

Imre Ungi , MD, PhD;

Bavana V. Rangan , BDS, MPH, MD;

Michael R. Wyman , MD;

Ajay J. Kirtane , MD, SM;

Subhash Banerjee , MD, FSCAI;

Nicholas J. Lembo , MD;

Barry F. Uretsky , MD;

David E. Kandzari , MD;

Anthony H. Doing , MD;

William L. Lombardi , MD;

Craig A. Thompson , MD, MMSc;

Ehtisham Mahmud , MD;

Catalin Toma , MD;

Mitul P. Patel , MD;

James W. Choi , MD;

Santiago Garcia , MD;

Aya J. Alame , BA;

Khaldoon Alaswad , MD;

José Roberto Martínez-Parachini , MD;

Erica Resendes , BS, MS, MPH;

Emmanouil S. Brilakis , MD, PhD, FACC, FAHA, FESC, FSCAI;

Jeffrey W. Moses , MD;

We examined the impact of proximal vessel tortuosity on the outcomes of chronic total occlusion percutaneous coronary intervention.

We examined the impact of...

05/15/2017

Journal of Invasive Cardiology

Review

Solving Challenging Situations and Complications in Everyday Percutaneous Coronary Intervention Using Chronic Total Occlusion Techniques

03/01/2020

Emmanouil S. Brilakis , MD, PhD, FACC, FAHA, FESC, FSCAI;

Barry F. Uretsky , MD;

Khaldoon Alaswad , MD;

Dimitrios Karmpaliotis , MD, PhD;

Masahisa Yamane , MD, PhD;

Stéphane Rinfret , MD, SM;

Soledad Ojeda , MD, PhD;

Lorenzo Azzalini , MD, PhD, MSc;

Manuel Pan , MD, PhD;

Kambis Mashayekhi , MD;

Luiz Fernando Ybarra , MD, PhD, MBA;

Alexandre Avran , MD, PhD;

Mauro Carlino , MD;

The challenging nature of CTO interventions involves regularly dealing with support-related issues, uncrossable/undilatable lesions, manipulation of equipment in the subadventitial space, and the treatment of complications such as perforation...

The challenging nature of CTO...

03/01/2020

Journal of Invasive Cardiology

Clinical Editor's Corner

On Teaching Cardiac Cath Part II: Where is Your Attending?

12/05/2014

Lloyd W. Klein , MD;

Robert J. Applegate , MD;

Augusto D. Pichard , MD, FACC, FSCAI;

Alan C. Yeung , MD;

Bonnie H. Weiner , MD, MBA, FSCAI, FACC;

Molly Szerlip , MD, FACP;

Morton J. Kern , MD, MSCAI, FACC, FAHA;

Mitchell W. Krucoff , MD;

Michael Ragosta , MD;

John W. Hirshfeld Jr.;

David J. Cohen , MD, MPH, MSc;

Kirk N. Garrett ;

Barry F. Uretsky , MD;

Larry S. Dean , MD, FACC, FAHA, FSCAI;

George W. Vetrovec , MD;

Andrew Doorey ;

Do people think it's okay for the attending to be outside in the monitor area, intermittently engaged in other activities while trainees do cases?

Do people think it's okay for...

12/05/2014

Cath Lab Digest

Original Contribution

Clinical Decision-Making for the Hemodynamic "Gray Zone" (FFR 0.75-0.80) and Long-Term Outcomes

04/15/2017

Shiv Kumar Agarwal , MD;

Srikanth R. Kasula , MD;

Sameer Raina , MD;

Fnu Shailesh , MD;

Jason J. Payne , MD;

Naga V. Pothineni , MD;

Abdul Hakeem , MD;

Barry F. Uretsky , MD;

Ahmed Almomani , MBBS, MD;

Mohan Mallikarjuna Rao Edupuganti , MD;

Fractional flow reserve (FFR) value between 0.75 and 0.80 is considered the "gray zone" and outcomes data relative to treatment strategy (revascularization vs medical therapy alone [deferral]) are limited for this group. A total of 238...

Fractional flow reserve (FFR)...

04/15/2017

Journal of Invasive Cardiology

Clinical Editor's Corner

Conversations in Cardiology: The End of End-hole Left Ventriculography – A Consensus of Operators

11/14/2013

Joseph D. Babb , MD;

George W. Vetrovec , MD;

John Bittl , MD;

Lloyd W. Klein , MD;

Allen Jeremias , MD, MSc;

Gregg W. Stone , MD, FACC, FSCAI;

Steven R. Bailey , MD;

Augusto D. Pichard , MD, FACC, FSCAI;

Frederick G.P. Welt , MD;

David G. Rizik , MD, FACC, FSCAI;

Mladen I. Vidovich , MD;

Bonnie H. Weiner , MD, MBA, FSCAI, FACC;

Morton J. Kern , MD, MSCAI, FACC, FAHA;

Charles E. Chambers , MD;

Christopher J. White , DO, MD;

Barry F. Uretsky , MD;

Peter Ver Lee , MD;

Mitchell W. Krucoff , MD;

Bernard DeBruyne ;

Kirk N. Garrett ;

Carl L. Tommaso , MD;

Malcolm R. Bell , MD;

Left ventriculography, once an integral part of every cardiac angiographic procedure, has been reconsidered as often unnecessary in light of high quality echocardiography for left ventricular (LV) functional assessment.

Left ventriculography, once an...

11/14/2013

Cath Lab Digest

Original Contribution

Utility of Frequency Domain Optical Coherence Tomographic Evaluation of Angiographically Optimized Stented Lesions

03/01/2016

Abdul Hakeem , MD;

Zubair Ahmed , MD;

Barry F. Uretsky , MD;

Mayank Agrawal , MD;

Post-PCI optical coherence tomography may be a clinically useful tool in angiographically optimized stenting. Prospective studies will provide further clarity on the place of OCT in this setting.

Post-PCI optical coherence...

03/01/2016

Journal of Invasive Cardiology

Original Contribution

Temporal Trends in Chronic Total Occlusion Percutaneous Coronary Interventions: Insights From the PROGRESS-CTO Registry

03/20/2020

Emad Hakemi , MD;

Santiago Garcia , MD;

Emmanouil S. Brilakis , MD, PhD, FACC, FAHA, FESC, FSCAI;

M. Nicholas Burke , MD;

Subhash Banerjee , MD, FSCAI;

Khaldoon Alaswad , MD;

Fotios Gkargkoulas , MD;

Shuaib M. Abdullah , MD;

Iosif Xenogiannis , MD;

Dimitrios Karmpaliotis , MD, PhD;

Allison Hall , MD;

Farouc A. Jaffer , MD, PhD;

Robert W. Yeh , MD, MBA, MSc;

Nicholas J. Lembo , MD;

Anthony H. Doing , MD;

Jeffrey W. Moses , MD;

Catalin Toma , MD;

Ziad A. Ali , MD, DPhil;

James W. Choi , MD;

Manish A. Parikh , MD;

Oleg Krestyaninov , MD;

Aris Karatasakis , MD;

Ehtisham Mahmud , MD;

Dmitrii Khelimskii , MD;

Barbara Anna Danek , MD;

Mitul P. Patel , MD;

Philip Dattilo , MD;

Bavana V. Rangan , BDS, MPH, MD;

Evangelia Vemmou , MD;

Ajay J. Kirtane , MD, SM;

Juan Russo , MD;

Ilias Nikolakopoulos , MD;

Barry F. Uretsky , MD;

Abstract: Background. Chronic total occlusion (CTO) percutaneous coronary intervention (PCI) has significantly evolved in recent years. Methods. We compared the clinical, angiographic, and technical characteristics, as well as procedural...

Abstract: Background. Chronic...

03/20/2020

Journal of Invasive Cardiology

Clinical Editor's Corner

Conversations in Cardiology – Heparin Potency: What is the Right Heparin Dose for PCI in 2021?

12/28/2020

Sunil V. Rao , MD, FACC, FSCAI;

Lloyd W. Klein , MD;

Morton J. Kern , MD, MSCAI, FACC, FAHA;

David J. Cohen , MD, MPH, MSc;

Timothy D. Henry , MD;

Nils P. Johnson , MD, MS;

Mitchell W. Krucoff , MD;

Barry F. Uretsky , MD;

Samuel M. Butman , MD;

Mauricio G. Cohen , MD, FACC;

Kreton Mavromatis , MD;

Steven R. Bailey , MD;

Malcolm R. Bell , MD;

James C. Blankenship , MD;

Watch/listen (video included in article below) as Dr. Kern and Dr. Arnold H. Seto discuss this article in a 30-minute Clinical Editor's Corner Live presentation that took place on Thurs, January 28th at 1:30pm ET.

Watch/listen (video included in...

12/28/2020

Cath Lab Digest

Substrate For Complications

07/02/2012

Rajesh Sachdeva , MD;

Ajay U. Mhatre , MD;

Barry F. Uretsky , MD;

ABSTRACT: Acute stent thrombosis is a rare, life-threatening, and challenging complication of left main stenting. Equally challenging is treating a chronic saphenous vein graft occlusion. Though considered class III indication per ACC/AHA...

ABSTRACT: Acute stent thrombosis...

07/02/2012

Journal of Invasive Cardiology